Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Lawmakers Want Answers From FDA On Infant Formula Shortage Following Abbott Recall

May 13 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Abbott Recalls Infant Formula Made At Facility FDA Is Investigating For Bacterial Contamination

Feb 18 2022

Califf Returns To US FDA Helm As Familiar Consumer Health Regulation Problems Continue

Feb 16 2022

Weighing Shortage Risk, FDA Clears Releasing Metabolic Formulas Made At Abbott’s Closed Plant

Apr 30 2022

Recall Sours Abbott’s Infant Formula Results; COVID-19 Test Sales Expected To Cool

Apr 20 2022

DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility

May 13 2022

Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request

May 30 2021

Related Companies

Reckitt Benckiser Group PLC

Additional Topics

International US States FDA Politics Safety Commercial Companies Compliance Consumer Dietary Supplements Enforcement Ingredients Legislation Manufacturing Policy Regulation Recalls

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window